Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.
Surgery Partners (NASDAQ:SGRY) & Healthways (TVTY) Critical Analysis
Surgery Partners (NASDAQ: SGRY) and Healthways (NASDAQ:TVTY) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitabiliy, valuation, dividends, earnings and risk.
Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.
Risk and Volatility
Surgery Partners has a beta of 1.86, suggesting that its stock price is 86% more volatile than the S&P 500. Comparatively, Healthways has a beta of 0.4, suggesting that its stock price is 60% less volatile than the S&P 500.
Insider and Institutional Ownership
39.2% of Surgery Partners shares are held by institutional investors. 7.5% of Surgery Partners shares are held by insiders. Comparatively, 8.4% of Healthways shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Profitability
This table compares Surgery Partners and Healthways’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Surgery Partners | 1.19% | 8.88% | 1.25% |
| Healthways | -18.90% | 37.59% | 11.18% |
Analyst Recommendations
This is a breakdown of current ratings and recommmendations for Surgery Partners and Healthways, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Surgery Partners | 0 | 1 | 3 | 0 | 2.75 |
| Healthways | 0 | 1 | 7 | 0 | 2.88 |
Surgery Partners presently has a consensus target price of $21.50, suggesting a potential upside of 0.70%. Healthways has a consensus target price of $32.19, suggesting a potential downside of 19.03%. Given Surgery Partners’ higher probable upside, equities research analysts plainly believe Surgery Partners is more favorable than Healthways.
Valuation & Earnings
This table compares Surgery Partners and Healthways’ revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | EBITDA | Earnings Per Share | Price/Earnings Ratio | |
| Surgery Partners | $1.14 billion | 0.91 | $245.68 million | $0.28 | 76.25 |
| Healthways | $515.96 million | 3.02 | $109.39 million | ($2.72) | -14.61 |
Surgery Partners has higher revenue and earnings than Healthways. Healthways is trading at a lower price-to-earnings ratio than Surgery Partners, indicating that it is currently the more affordable of the two stocks.
Summary
Surgery Partners beats Healthways on 8 of the 14 factors compared between the two stocks.
Surgery Partners Company Profile
Healthways Company Profile